BNP Paribas Financial Markets
TNGX icon

BNP Paribas Financial Markets’s Tango Therapeutics TNGX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Sell
25,412
-5,213
-17% -$129K ﹤0.01% 3473
2026
Q1 		$641K Buy
30,625
+21,062
+220% +$293K ﹤0.01% 3455
2025
Q4 		$84.7K Sell
9,563
-5,527
-37% -$47.6K ﹤0.01% 4445
2025
Q3 		$127K Buy
15,090
+6,481
+75% +$43.9K ﹤0.01% 4198
2025
Q2 		$44.1K Sell
8,609
-38,920
-82% -$96.2K ﹤0.01% 4303
2025
Q1 		$65.1K Buy
47,529
+40,836
+610% +$100K ﹤0.01% 4198
2024
Q4 		$20.7K Buy
+6,693
New +$31.1K ﹤0.01% 4714

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's TNGX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Tango Therapeutics (TNGX) stake by 17% in Q2 2026, selling an estimated $129K and leaving 25,412 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #3473.

BNP Paribas Financial Markets first reported a position in TNGX in Q4 2024 and has held it in 7 quarters since. 230 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • BNP Paribas Financial Markets held 25,412 shares of Tango Therapeutics worth $794K as of Q2 2026.
  • BNP Paribas Financial Markets sold 5,213 Tango Therapeutics shares in Q2 2026, an estimated $129K.
  • Tango Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3473 holding.
  • BNP Paribas Financial Markets first reported a position in Tango Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 230 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.